Latest Updates

Introduction Phytopharmaceuticals in India: Bridging Tradition, Science and “New Drug”-Style Regulation Setting the stage…

Company responds to regulatory action and outlines guidance on procurement and product identification

Voucher granted for Sezaby approval to be divested under asset purchase agreement

Acquisition integrates AI-enabled PV solutions with clinical and safety services

Refresher session scheduled on April 29 for industry members and regulators

Market authorisation covers 2 mg and 4 mg pen presentations in Canada

Symposium focuses on translating research into clinical application in ophthalmology

Therapy targets gram-negative bacterial infections in critical care settings

Appointment to focus on private equity and M&A advisory in life sciences sector

Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections

Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; market size at US$ 145 million

The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform brought together FR&D leaders to discuss…

Former Cipla CEO to lead next phase for CDMO platform focused on complex chemistry and APIs

Five-year agreement focuses on open science access, joint research and capability building

Deal combines portfolios and expands presence across women’s health, biosimilars and global markets

Agreements focus on medicine quality testing, pharmacovigilance, and pharmaceutical research collaboration

Company outlines expansion across multiple states and pipeline of formulations under development

Transaction to create integrated global biosimilars platform combining development, manufacturing and commercial capabilities

Platform to support workforce development for quality, production and regulatory roles

Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover…